Dyskinesia
Dyskinesia refers to a category of
Types
Medication-induced dyskinesias
Acute dystonia is a sustained muscle contraction that sometimes appears soon after administration of antipsychotic medications.[4] Any muscle in the body may be affected, including the jaw, tongue, throat, arms, or legs. When the throat muscles are involved, this type of dystonia is called an acute laryngospasm and is a medical emergency because it can impair breathing.[4] Older antipsychotics such as Haloperidol or Fluphenazine are more likely to cause acute dystonia than newer agents. Giving high doses of antipsychotics by injection also increases the risk of developing acute dystonia.[4]
- Off-period dystonia – correlated to the
- Diphasic dyskinesia – occurs when
- Peak-dose dyskinesia – the most common form of levodopa-induced dyskinesia; it correlates with the plateau L‑DOPA plasma level. This type usually involves the upper limbs more (but could also affect the head, trunk and respiratory muscles), is choreic (of chorea), and less disabling. Patients will respond to L‑DOPA reduction but may be accompanied by deterioration of parkinsonism.[8][9] Peak-dose L-DOPA-induced dyskinesia has recently[update] been suggested to be associated with cortical dysregulation of dopamine signaling.[10]
Chronic or tardive
Late-onset dyskinesia, also known as tardive dyskinesia, occurs after long-term treatment with an antipsychotic drug such as haloperidol (Haldol) or amoxapine (Asendin). The symptoms include tremors and writhing movements of the body and limbs, and abnormal movements in the face, mouth, and tongue – including involuntary lip smacking, repetitive pouting of the lips, and tongue protrusions.[11]
Non-motor
Two other types, primary ciliary dyskinesia and biliary dyskinesia, are caused by specific kinds of ineffective movement of the body, and are not movement disorders.
See also
References
- ^ "Dyskinesia (Health Article)". Yahoo! Health. Retrieved 25 January 2014.
- ^ "dyskinesia" at Dorland's Medical Dictionary
- ^ Healy 2008, p. 29-30.
- ^ ISBN 978-1609137137.
- PMID 21803215.
- . Retrieved 28 November 2017.
- PMID 27519465.
- ^ a b c d
Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG (April 2007). "Levodopa-induced dyskinesias". Movement Disorders. 22 (10): 1379–89. S2CID 20926751.
- ^ a b c d
Thanvi B, Lo N, Robinson T (June 2007). "Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment". Postgraduate Medical Journal. 83 (980): 384–88. PMID 17551069.(full free text)
- ^
Halje P, Tamtè M, Richter U, Mohammed M, Cenci MA, Petersson P (November 2012). "Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations". Journal of Neuroscience. 32 (47): 16541–51. PMID 23175810.(full free text)
- ^ Healy 2008, p. 30–31.
- ^
Gonzales GR (July 1992). "Postherpes simplex type 1 neuralgia simulating postherpetic neuralgia". J Pain Symptom Manage. 7 (5): 320–3. PMID 1624816.
Works cited
- Healy, David (2008). Psychiatric Drugs Explained. Elsevier Health Sciences. ISBN 978-0-7020-2997-4.